MEI Pharma Announces Enrollment Initiated In 12-Patient Expansion Cohort Evaluating Voruciclib Plus Venetoclax In Ongoing Phase 1 Study; Says Anti-leukemic Activity Across Multiple Heavily Pretreated Patients Demonstrated Along With Anticipated Decreases In Mcl-1
MEI Pharma宣布在进行中的1期研究中，在评估Voruciclib Plus Venetoclax的12名患者扩大队列中启动了招募工作；称多名经过大量预治疗的患者的抗白血病活性已显示出来，而且预计Mcl-1的降低